TNKASE (tenecteplase) - Roche, Boehringer Ingelheim
IAT-MEVO: Intra-arterial Thrombolysis For Acute Ischemic Stroke With Medium Vessel Occlusion (clinicaltrials.gov) - Sep 24, 2026 - P3 | N=372 | Recruiting | Sponsor: The First Affiliated Hospital with Nanjing Medical University | Not yet recruiting ➔ Recruiting | Trial completion date: Aug 2029 ➔ May 2029 | Trial primary completion date: Jul 2028 ➔ Jan 2029 
Enrollment open • Trial completion date • Trial primary completion date • Cardiovascular • Ischemic stroke
http://clinicaltrials.gov/ct2/show/NCT07668323
 
Sep 24, 2026
 
Prev Next